Reduced access to gastric motility drug will not sit well with many physicians or patients.
Gordon
D
D
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D020117:Cisapride / Q000009:adverse effects* / Q000627:therapeutic use; D004335:Drug and Narcotic Control; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans
D005765:Gastrointestinal Agents; D020117:Cisapride